Cookies on Pinsent Masons website

This website uses cookies to allow us to see how the site is used. The cookies cannot identify you. If you continue to use this site we will assume that you are happy with this

If you want to use the sites without cookies or would like to know more, you can do that here.

NICE calls for review into way drugs are developed, evaluated and adopted in the NHS

A review into drugs "innovation, evaluation and adoption" within the NHS has been called for by the National Institute for Health and Care Excellence (NICE). 19 Sep 2014

Health bodies must pro-actively disclose details of meetings with pharmaceutical companies, says ICO

Public health bodies in England, Wales and Northern Ireland must pro-actively disclose details of the meetings they hold with pharmaceutical companies and other medical suppliers, the Information Commissioner's Office (ICO) has said. 18 Sep 2014

Out-Law Guides

More guides

Cancer cell treatment first to be classed 'promising innovative medicine' under UK fast-track drugs scheme

A drug aimed at helping human immune systems to identify and kill cancer cells is the first to be classified as a 'promising innovative medicine' (PIM) under a UK scheme that aims to speed up the delivery of medicines to patients, the UK government has announced.... 17 Sep 2014

UK Takeover Code to distinguish between offer "commitments" and "intentions"

The body which oversees and regulates UK takeovers has proposed stricter regulation of commitments made by parties to an offer during acquisition talks, as distinguished from the parties' broad intentions. 16 Sep 2014

More stories